BALTHASER KEVIN (Chief Financial Officer) exercised options at ACLARIS THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/3/2026ACC: 0001957554-26-000005
Officer· Chief Financial Officer
Since Mar 2026
-4.98K
Net shares
Net seller
$17.5K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
14.75K acquired · 19.73K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.75K
Price / share
—
Trade value
—
% of position
9.2%
2/1/2026
160.41K→175.16K
Common Stock
Direct
Shares
−4.98K
Price / share
$3.51
Trade value
$17.49K
% of position
2.8%
2/1/2026
175.16K→170.18K
Total
Net shares
+9.77K
Net value
-$17.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2026 | M · Option Exercise | +14.75K | — | — | 9.2% | 160.41K | 175.16K |
| Common Stock Direct | 2/1/2026 | F · Tax Withholding | −4.98K | $3.51 | $17.49K | 2.8% | 175.16K | 170.18K |
| Total | +9.77K | -$17.49K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
14.75K shares
Shares
−14.75K
Strike price
Held after
29.50K
Exercisable
—
2/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock14.75K shares | 2/1/2026 | M · Option Exercise | −14.75K | — | 29.50K |